Cart
0

Transplant Diagnostics Market by Molecular and Non-Molecular Assay Technology (Serological assay, Mixed Lymphocyte Culture, PCR Based, Sequencing Based), End-User (Hospitals and transplant centers, Research laboratories and academic institutes, Commercial Service Providers) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

Get 20% Free Customization In This Report
LI_161135
Pages: 138
Sep 2016 | 2295 Views
 
Author's : Onkar Sumant
Tables: 66
Charts: 55
 

Transplant Diagnostics Market Overview : 

Transplant Diagnostics Market was valued at $524.7 million, and is expected to reach $1,031 million by 2022, supported by a CAGR of 10%. Transplant diagnostics are tests done to check the compatibility between the donor and recipient of organ before or after transplant.

The adoption of transplant diagnostics (including both pre- and post-transplant screening) is expected to witness a significant rise with increasing prevalence of chronic diseases that can lead to organ failure. The market has gained the interest of healthcare providers owing to various benefits offered by these tests to assess the feasibility of the organ transplant procedure. There have been significant technological advancements in transplant diagnostics to provide advanced diagnostics options for the management of organ transplant. The market is in a mature phase in the developed countries, while the emerging regions such as LAMEA and Asia-Pacific hold potential opportunities for transplant diagnostics. 

World Transplant Diagnostics Market

Transplant Diagnostics Market

Get more information on this report : Request Sample Pages

Subject Matter Expert (SMEs) Perspective

According to the perspectives of SMEs of leading companies, growing number of organ transplant procedures, technological advancements, rising incidence of chronic diseases, and increased R&D activities drive this market. However, organ shortage for transplant procedures, challenges in sequencing HLA, and lack of awareness hinder the market growth. Currently, the consumables segment generates maximum revenue. According to the SMEs, the increasing need for organ transplants creates a demand for transplant diagnostics. In addition, majority of the transplant diagnostic manufacturers and distributors focus more on emerging markets due to the potential they hold. The growing burden of chronic diseases in emerging nations is the leading factor for growing focus toward these regions. As per SMEs, North America is expected to dominate the market during the forecast period, followed by Europe.

Driving Force for Transplant Diagnostics Market

One of the major concern globally is the increasing geriatric population. The world population was around 7.34 billion in 2015, while the geriatric population (60+ years) accounted for around 901 million, which is expected to reach around 1.4 billion by 2030. This burden of the continuously rising elderly population drives the transplant diagnostics market, as transplant procedures are majorly required for people above the age of 60, owing to the presence of chronic disease. Thus, the major patient pool for transplant diagnostics is concentrated in this age group, which is expected to drive the transplant diagnostics market. 

Transplant Procedures in The U.S, by Age, 2015

Transplant Procedures in The U.S by Age

Get more information on this report : Request Sample Pages

Asia had the highest geriatric population in 2015, reported to be 508 million, followed by Europe with 176.5 million. Asia thus holds major potential for the transplant diagnostics market.

Italy: Transplant Diagnostics Market, 2014‐2022 ($Million)

Italy Transplant Diagnostics Market

Get more information on this report : Request Sample Pages

Italy transplant diagnostics market revenue were valued at $5.79 million in 2015, and is expected to reach $10.86 million by 2022, registering a CAGR 9.4% from 2016 to 2022. Increase in awareness among people related to the importance of organ transplantation has been an ongoing trend in the European countries. This has resulted in increasing number of organ donations especially from living donors.
The report also provides comprehensive analysis of the key players operating in the global transplant diagnostics market such as Abbott Laboratories Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche, Ltd., Illumina, Inc., Immucor, Inc., Linkage Biosciences, Olerup Ssp Ab, Qiagen N.V., Thermo Fisher Scientific Inc., and Sigma-Aldrich including others. The report presents competitive market study by analyzing market shares and position of major players, recent strategic moves and detailed profiles of these players.

Transplant Diagnostics Market Key Benefits:

  • The study provides an in-depth analysis of the global transplant diagnostics market with current trends and future estimations to elucidate the imminent investment pockets.
  • The report provides a quantitative analysis from 2014 to 2022, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
  • Extensive analysis by product helps in understanding the various types of diagnostic tests used for organ transplant procedures and related conditions. 
  • Competitive intelligence helps in understanding the competitive scenario across the geographies
  • Key market players within the global transplant diagnostics market are profiled in this report and their strategies are analyzed thoroughly, which helps in understanding competitive outlook of the market. 

Transplant Diagnostics Market Key Segments

The global transplant diagnostics market is segmented based on technology, components, end-user, applications, organ type, screening type, and geography.

Transplant Diagnostics Market By Technology 

  • Non-Molecular assay
    • Serological assay
    • Mixed Lymphocyte Culture
  • Molecular assay
    • PCR Based
    • Sequencing Based

Transplant Diagnostics Market By Component 

  • Instrument and Equipment
  • Reagent and consumables
  • Software and services

Transplant Diagnostics Market By End-User 

  • Hospitals and transplant centers 
  • Research laboratories and academic institutes 
  • Commercial Service Providers

Transplant Diagnostics Market By Applications 

  • Research
  • Diagnostic

Transplant Diagnostics Market By Organ Type 

  • Kidney 
  • Liver
  • Heart 
  • Lung 
  • Pancreas
  • Others

Transplant Diagnostics Market By Screening Type 

  • Pre-Transplant Screening 
  • Post-Transplant Screening

Transplant Diagnostics Market By Region

  • North America
    • U.S.
    • Canada
    • Mexico    
    • Rest of North America
  • Europe    
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • Turkey 
    • Rest of Europe
  • Asia-Pacific
    • Australia 
    • South Korea
    • New Zealand 
    • Japan
    • China
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil 
    • Israel
    • Iran 
    • Saudi Arabia
    • Rest of LAMEA  

       

 

 

Chapter: 1 INTRODUCTION

1.1 Report description
1.2 Key Benefits
1.3 Key Market Segments
1.4 Research Methodology

1.4.1 Saecondary Research
1.4.2 Primary Research
1.4.3 Analyst Tools and Models

Chapter: 2 EXECUTIVE SUMMARY

2.1 CXO Perspective

Chapter: 3 MARKET OVERVIEW

3.1 Market Definition and Scope
3.2 Key Findings

3.2.1 Top Investment Pockets
3.2.2 Top Winning Strategies

3.3 Porters Five Forces Analysis

3.3.1 Bargaining Power of Suppliers
3.3.2 Bargaining Power of Buyers
3.3.3 Threat of New Entrants
3.3.4 High Intensity of Rivalry
3.3.5 Threat of Substitutes

3.4 Top Player Positioning, 2015
3.5 Market Dynamics

3.5.1 Drivers

3.5.1.1 Increasing aging population
3.5.1.2 Increased incidence of chronic diseases
3.5.1.3 Increased focus on R&D

3.5.2 Restraints

3.5.2.1 organ shortage worldwide
3.5.2.2 Difficulties in HLA sequencing

3.5.3 Opportunities

3.5.3.1 Shift from traditional methods to modern techniques for HLA typing
3.5.3.2 Increasing demand for organ transplant procedures
3.5.3.3 Mergers & acquisitions

Chapter: 4 WORLD TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY

4.1 Overview

4.1.1 Market Size and Forecast

4.2 Non-Molecular Assays

4.2.1 Key Market Trends
4.2.2 Key Growth Factors and Opportunities
4.2.3 Market Size and Forecast
4.2.4 Serological Assays

4.2.4.1 Market size and forecast

4.2.5 Mixed Lymphocyte Culture Assays

4.2.5.1 Market size and forecast

4.3 Molecular Assays

4.3.1 Key Market Trends
4.3.2 Key Growth Factors and Opportunities
4.3.3 Market Size and Forecast

4.3.3.1 PCR-based molecular assay
4.3.3.2 Market size and forecast
4.3.3.3 sequencing-based molecular assay
4.3.3.4 Market size and forecast

Chapter: 5 WORLD TRANSPLANT DIAGNOSTICS MARKET, BY COMPONENT

5.1 Overview
5.2 Consumables and Reagents

5.2.1 Market Size and Forecast

5.3 Instruments and Equipment

5.3.1 Market Size and Forecast

5.4 Software and Services

5.4.1 Market Size and Forecast

Chapter: 6 WORLD TRANSPLANT DIAGNOSTICS MARKET, BY END USER

6.1 Overview

6.1.1 Market Size and Forecast

6.2 Hospitals and Transplant Centers

6.2.1 Market Size and Forecast

6.3 Research Laboratories and Academic Institutions

6.3.1 Market Size and Forecast

6.4 Commercial Service Providers

6.4.1 Market Size and Forecast

Chapter: 7 WORLD TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION

7.1 Overview
7.2 Research

7.2.1 Market Size and Forecast

7.3 Diagnostics

7.3.1 Market Size and Forecast

Chapter: 8 WORLD TRANSPLANT DIAGNOSTICS MARKET BY ORGAN TYPE

8.1 Overview
8.2 Kidney

8.2.1 Market size and forecast

8.3 Liver

8.3.1 Market size and forecast

8.4 Heart

8.4.1 Market size and forecast

8.5 Lung

8.5.1 Market size and forecast

8.6 Pancreas

8.6.1 Market size and forecast

8.7 Others

8.7.1 Market size and forecast

Chapter: 9 WORLD TRANSPLANT DIAGNOSTICS MARKET, BY TYPE OF SCREENING

9.1 Overview
9.2 Pretransplant Screening

9.2.1 Market Size and Forecast

9.3 Posttransplant Screening

9.3.1 Market Size and Forecast

Chapter: 10 WORLD TRANSPLANT DIAGNOSTICS MARKET, BY GEOGRAPHY

10.1 Overview

10.1.1 Market Size and Forecast

10.2 North America

10.2.1 Key Market Trends
10.2.2 Key Growth Factors and Opportunities
10.2.3 Market Size and Forecast
10.2.4 U.S.: Market Size and Forecast
10.2.5 Canada: Market Size and Forecast
10.2.6 Mexico: Market Size and Forecast

10.3 Europe

10.3.1 Key Market Trends
10.3.2 Key Growth Factors and Opportunities
10.3.3 Market Size and Forecast
10.3.4 UK: Market Size and Forecast
10.3.5 Germany: Market Size and Forecast
10.3.6 France: Market Size and Forecast
10.3.7 Spain: Market Size and Forecast
10.3.8 Italy: Market Size and Forecast
10.3.9 Turkey: Market Size and Forecast
10.3.10 Rest of Europe: Market Size and Forecast

10.4 Asia-Pacific

10.4.1 Key Market Trends
10.4.2 Key Growth Factors and Opportunities
10.4.3 Market Size and Forecast
10.4.4 Australia: Market Size and Forecast
10.4.5 South Korea: Market Size and Forecast
10.4.6 New Zealand: Market Size and Forecast
10.4.7 China: Market Size and Forecast
10.4.8 Japan: Market Size and Forecast
10.4.9 Rest of Asia-Pacific: Market Size and Forecast

10.5 LAMEA

10.5.1 Key Market Trends
10.5.2 Key Growth Factors and Opportunities
10.5.3 Market Size and Forecast
10.5.4 Brazil: Market Size and Forecast
10.5.5 Israel: Market Size and Forecast
10.5.6 Iran: Market Size and Forecast
10.5.7 Saudi Arabia: Market Size and Forecast
10.5.8 Rest of LAMEA: Market Size and Forecast

Chapter: 11 COMPANY PROFILES

11.1 Immucor, Inc. (TPG Capital)

11.1.1 Company overview
11.1.2 Operating business segments
11.1.3 Business performance
11.1.4 Key strategic moves & developments

11.2 Bio-Rad Laboratories, Inc.

11.2.1 Company overview
11.2.2 Operating business segments
11.2.3 Business performance
11.2.4 Key strategic moves & developments

11.3 Thermo Fisher Scientific Inc.

11.3.1 Company overview
11.3.2 Operating business segments
11.3.3 Business performance
11.3.4 Key strategic moves & developments

11.4 F. Hoffmann-la Roche AG

11.4.1 Company overview
11.4.2 Operating business segments
11.4.3 Business performance
11.4.4 Key strategic moves & developments

11.5 Illumina, Inc.

11.5.1 Company overview
11.5.2 Operating business segments
11.5.3 Business performance
11.5.4 Key strategic moves & developments

11.6 Abbott Laboratories

11.6.1 Company overview
11.6.2 Operating business segments
11.6.3 Business performance
11.6.4 Key strategic moves & developments

11.7 Sigma-Aldrich Corporation

11.7.1 Company overview
11.7.2 Operating business segments
11.7.3 Business performance

11.8 Qiagen N.V.

11.8.1 Company overview
11.8.2 Operating business segments
11.8.3 Business performance
11.8.4 Key strategic moves & developments

11.9 Olerup SSP AB (Allenex)

11.9.1 Company overview
11.9.2 Key strategic moves & developments

11.10 DiaSorin S.P.A.

11.10.1 Company overview
11.10.2 Operating business segments
11.10.3 Business performance
11.10.4 Key strategic moves & developments

List of Figures

FIG. 1 TOP INVESTMENT POCKETS IN WORLD TRANSPLANT DIAGNOSTICS MARKET
FIG. 2 TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (20112016)
FIG. 3 TOP WINNING STRATEGIES: NATURE & TYPE
FIG. 4 PORTERS FIVE FORCES ANALYSIS
FIG. 5 TRANSPLANT DIAGNOSTICS MARKET TOP PLAYER POSITIONING, 2015
FIG. 6 WORLD GERIATRIC POPULATION, BY REGION, 2015
FIG. 7 TRANSPLANT PROCEDURES IN THE U.S., BY AGE, 2015
FIG. 8 WAITING LIST IN U.S. FOR ORGAN TRANSPLANTATION BY TYPE OF ORGAN
FIG. 9 U.S.: TRANSPLANT DIAGNOSTICS MARKET, 20142022 ($MILLION)
FIG. 10 CANADA: TRANSPLANT DIAGNOSTICS MARKET, 20142022 ($MILLION)
FIG. 11 MEXICO: TRANSPLANT DIAGNOSTICS MARKET, 20142022 ($MILLION)
FIG. 12 U.K.: TRANSPLANT DIAGNOSTICS MARKET, 20142022 ($MILLION)
FIG. 13 GERMANY: TRANSPLANT DIAGNOSTICS MARKET, 20142022 ($MILLION)
FIG. 14 FRANCE: TRANSPLANT DIAGNOSTICS MARKET, 20142022 ($MILLION)
FIG. 15 SPAIN: TRANSPLANT DIAGNOSTICS MARKET, 20142022 ($MILLION)
FIG. 16 ITALY: TRANSPLANT DIAGNOSTICS MARKET, 20142022 ($MILLION)
FIG. 17 TURKEY: TRANSPLANT DIAGNOSTICS MARKET, 20142022 ($MILLION)
FIG. 18 REST OF EUROPE: TRANSPLANT DIAGNOSTICS MARKET, 20142022 ($MILLION)
FIG. 19 AUSTRALIA: TRANSPLANT DIAGNOSTICS MARKET, 20142022 ($MILLION)
FIG. 20 SOUTH KOREA: TRANSPLANT DIAGNOSTICS MARKET, 20142022 ($MILLION)
FIG. 21 NEW ZEALAND: TRANSPLANT DIAGNOSTICS MARKET, 20142022 ($MILLION)
FIG. 22 CHINA: TRANSPLANT DIAGNOSTICS MARKET, (20142022) ($MILLION)
FIG. 23 JAPAN: TRANSPLANT DIAGNOSTICS MARKET, 20142022 ($MILLION)
FIG. 24 REST OF ASIA-PACIFIC: TRANSPLANT DIAGNOSTICS MARKET, (20142022) ($MILLION)
FIG. 25 BRAZIL: TRANSPLANT DIAGNOSTICS MARKET, 20142022 ($MILLION)
FIG. 26 ISRAEL: TRANSPLANT DIAGNOSTICS MARKET, 20142022 ($MILLION)
FIG. 27 IRAN: TRANSPLANT DIAGNOSTICS MARKET, 20142022 ($MILLION)
FIG. 28 SAUDI ARABIA TRANSPLANT DIAGNOSTICS MARKET, 20142022 ($MILLION)
FIG. 29 REST OF LAMEA TRANSPLANT DIAGNOSTICS MARKET, 20142022 ($MILLION)
FIG. 30 IMMUCOR: REVENUE, 20132015, ($MILLION)
FIG. 31 IMMUCOR: REVENUE, BY BUSINESS SEGMENT, 2015(%)
FIG. 32 IMMUCOR: REVENUE, BY GEOGRAPHY, 2015, (%)
FIG. 33 BIO-RAD: SALES, 20132015, ($MILLION)
FIG. 34 BIO-RAD: SALES, BY BUSINESS SEGMENT, 2015 (%)
FIG. 35 BIO-RAD: SALES, BY GEOGRAPHY, 2015(%)
FIG. 36 THERMO FISHER: REVENUE, 20132015 ($MILLION)
FIG. 37 THERMO FISHER: REVENUE, BY BUSINESS SEGMENT, 2015, (%)
FIG. 38 THERMO FISHER: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 39 ROCHE: REVENUE, 20132015 ($MILLION)
FIG. 40 ROCHE: REVENUE, BY BUSINESS SEGMENT, 2015(%)
FIG. 41 ROCHE: REVENUE, BY GEOGRAPHY, 2015(%)
FIG. 42 ILLUMINA: REVENUE, 20132015 ($MILLION)
FIG. 43 ILLUMINA: REVENUE, BY SEGEMNT, 2015 (%)
FIG. 44 ILLUMINA: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 45 ABBOTT: REVENUE, 20132015 ($MILLION)
FIG. 46 ABBOTT: REVENUE, BY BUSINESS SEGMENT, 2015 (%)
FIG. 47 ABBOTT: REVENUE, BY GEOGRAPHY, 20132015 ($MILLION)
FIG. 48 SIGMA-ALDRICH: REVENUE, 20132014 ($MILLION)
FIG. 49 SIGMA-ALDRICH: REVENUE, BY BUSINESS UNITS, 2014 (%)
FIG. 50 SIGMA-ALDRICH: REVENUE, BY GEOGRAPHY, 2014 (%)
FIG. 51 QIAGEN N.V.: REVENUE, 20132015 ($MILLION)
FIG. 52 QIAGEN N.V.: REVENUE, BY BUSINESS SEGMENT, 2015 (%)
FIG. 53 QIAGEN N.V.: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 54 DIASORIN: REVENUE, 20132015 ($MILLION)
FIG. 55 DIASORIN: REVENUE, BY GEOGRAPHY, 2015 (%)

List of Tables

TABLE 1 WORLDWIDE SCENARIO FOR CHRONIC DISEASES CAUSING DEATH
TABLE 2 TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 20152022 ($MILLION)
TABLE 3 TRANSPLANT DIAGNOSTICS TECHNOLOGY MARKET, BY GEOGRAPHY, 20152022 ($MILLION)
TABLE 4 NON-MOLECULAR ASSAYS MARKET, BY TECHNOLOGY, 20142022 ($MILLION)
TABLE 5 NON-MOLECULAR ASSAYS MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 6 SEROLOGICAL ASSAYS MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 7 WORLD MIXED LYMPHOCYTE CULTURE ASSAYS MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 8 MOLECULAR ASSAYS TECHNOLOGY MARKET, 20142022 ($MILLION)
TABLE 9 MOLECULAR ASSAYS MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 10 PCR-BASED MOLECULAR ASSAY, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 11 SEQUENCING-BASED MOLECULAR ASSAY, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 12 WORLD TRANSPLANT DIAGNOSTICS MARKET, BY COMPONENT, 20142022 ($MILLION)
TABLE 13 WORLD TRANSPLANT DIAGNOSTICS COMPONENT MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 14 WORLD TRANSPLANT CONSUMABLES MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 15 WORLD TRANSPLANT DIAGNOSTICS INSTRUMENTS MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 16 WORLD TRANSPLANT DIAGNOSTICS SOFTWARE MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 17 WORLD TRANSPLANT DIAGNOSTICS SERVICES MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 18 WORLD TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 20142022 ($MILLION)
TABLE 19 WORLD TRANSPLANT DIAGNOSTICS END USER MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 20 WORLD HOSPITALS AND TRANSPLANT CENTERS MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 21 WORLD RESEARCH LABORATORIES AND ACADEMIC INSTITUTIONS MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 22 WORLD COMMERCIAL SERVICE PROVIDERS MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 23 WORLD TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATIONS, 20142022 ($MILLION)
TABLE 24 WORLD TRANSPLANT DIAGNOSTICS APPLICATIONS MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 25 WORLD RESEARCH MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 26 WORLD DIAGNOSTICS MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 27 TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE, 20142022 ($MILLION)
TABLE 28 TRANSPLANT DIAGNOSTICS ORGAN TYPE MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 29 TRANSPLANT DIAGNOSTICS MARKET FOR KIDNEY, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 30 TRANSPLANT DIAGNOSTICS MARKET FOR LIVER, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 31 TRANSPLANT DIAGNOSTICS MARKET FOR HEART, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 32 TRANSPLANT DIAGNOSTICS MARKET FOR LUNGS, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 33 TRANSPLANT DIAGNOSTICS MARKET FOR PANCREAS, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 34 WORLD TRANSPLANT DIAGNOSTICS MARKET FOR OTHER ORGANS, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 35 WORLD TRANSPLANT DIAGNOSTICS MARKET, BY TYPE OF SCREENING, 20142022 ($MILLION)
TABLE 36 WORLD TRANSPLANT DIAGNOSTICS SCREENING MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 37 WORLD PRE-SCREENING MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 38 WORLD POST-SCREENING MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 39 WORLD TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 20142022 ($MILLION)
TABLE 40 NORTH AMERICAN TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 20142022 ($MILLION)
TABLE 41 NORTH AMERICAN TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 42 EUROPEAN TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 20142022 ($MILLION)
TABLE 43 EUROPEAN TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 44 ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 45 ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 46 LAMEA TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT, 20142022 ($MILLION)
TABLE 47 LAMEA TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 49 IMMUCOR: OPERATING SEGMENTS
TABLE 51 BIO-RAD: OPERATING SEGMENTS
TABLE 53 THERMO FISHER: OPERATING SEGMENTS
TABLE 55 ROCHE: OPERATING SEGMENTS
TABLE 57 ILLUMINA: OPERATING SEGMENTS
TABLE 59 ABBOTT: OPERATING SEGMENTS
TABLE 61 SIGMA-ALDRICH: OPERATING SEGMENTS
TABLE 63 QIAGEN N.V.: OPERATING SEGMENTS
TABLE 66 DIASORIN: OPERATING SEGMENTS

 
 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Request Sample

Request Customization

Request sample

OR

Purchase Full Report of
Transplant Diagnostics Market- Global Opportunity Analysis and Industry Forecast, 2014 - 2022

  • Online Only
  • $3690
  • Online cloud Access only
  • Restricted Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $4099
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $4999
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6004
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprise
    License/PDF

  • $8373
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo